Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome
ConclusionNeoadjuvant chemoradiotherapy with and without hyperthermia for retroperitoneal sarcomas is feasible and provided high local control of intermediate- and high-grade sarcoma.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Anemia | Cancer & Oncology | Chemotherapy | Leiomyosarcoma | Liposarcoma | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Sarcomas | Thrombocytopenia | Toxicology